229 related articles for article (PubMed ID: 15843558)
21. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
22. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
Khanna R; Burrows SR; Nicholls J; Poulsen LM
Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
[TBL] [Abstract][Full Text] [Related]
23. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
[TBL] [Abstract][Full Text] [Related]
24. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
Annels NE; Callan MF; Tan L; Rickinson AB
J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
[TBL] [Abstract][Full Text] [Related]
25. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
26. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
[TBL] [Abstract][Full Text] [Related]
27. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
[TBL] [Abstract][Full Text] [Related]
28. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
29. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
[TBL] [Abstract][Full Text] [Related]
30. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
[TBL] [Abstract][Full Text] [Related]
31. HLA-B7 beta-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses.
Freese A; Zavazava N
Blood; 2002 May; 99(9):3286-92. PubMed ID: 11964295
[TBL] [Abstract][Full Text] [Related]
32. The shaping of T cell receptor recognition by self-tolerance.
Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
[TBL] [Abstract][Full Text] [Related]
33. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of direct alloreactivity of an HLA-B27-specific CTL clone by altered peptide ligands of its natural epitope.
García-Peydró M; Paradela A; Albar JP; Castro JA
J Immunol; 2000 Nov; 165(10):5680-5. PubMed ID: 11067925
[TBL] [Abstract][Full Text] [Related]
35. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma.
Winter D; Fiebiger E; Meraner P; Auer H; Brna C; Strohal R; Trautinger F; Knobler R; Fischer GF; Stingl G; Maurer D
J Immunol; 2003 Sep; 171(5):2714-24. PubMed ID: 12928425
[TBL] [Abstract][Full Text] [Related]
36. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Valmori D; Fonteneau JF; Lizana CM; Gervois N; Liénard D; Rimoldi D; Jongeneel V; Jotereau F; Cerottini JC; Romero P
J Immunol; 1998 Feb; 160(4):1750-8. PubMed ID: 9469433
[TBL] [Abstract][Full Text] [Related]
37. Tissue specificity of cross-reactive allogeneic responses by EBV EBNA3A-specific memory T cells.
D'Orsogna LJ; Roelen DL; van der Meer-Prins EM; van der Pol P; Franke-van Dijk ME; Eikmans M; Anholts J; Rossjohn J; McCluskey J; Mulder A; van Kooten C; Doxiadis II; Claas FH
Transplantation; 2011 Mar; 91(5):494-500. PubMed ID: 21242884
[TBL] [Abstract][Full Text] [Related]
38. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
[TBL] [Abstract][Full Text] [Related]
39. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
40. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.
Koning D; Costa AI; Hoof I; Miles JJ; Nanlohy NM; Ladell K; Matthews KK; Venturi V; Schellens IM; Borghans JA; Kesmir C; Price DA; van Baarle D
J Immunol; 2013 Feb; 190(3):931-9. PubMed ID: 23267020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
